Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT01496651
Eligibility Criteria:
Inclusion Criteria:
* Stable, unstable angina pectoris or ACS.
* Significant lesion\* of LMCA ostium, mid-shaft and/or bifurcation and with no more than three additional non-complex\*\* PCI lesions.
* Patient eligible to be treated by CABG and by PCI
* Signed informed consent. \*Visually assessed diameter stenosis \>50% or fractional flow reserve \<0.80. \*\*Length \<25 mm, non-CTO, non-2-stent bifurcation, non-calcified and non-tortuous vessel morphology coronary lesion.
Exclusion Criteria:
* ST-elevation infarction within 24 hours.
* CABG clearly better treatment option (LMCA stenosis and \>3, or complex\*\* additional coronary lesions)
* Patient is in too high risk for CABG.
* Expected survival \<1 year.
* Allergy to aspirin, clopidogrel or ticlopidine.
* Allergy to Biolimus. \*\*Length \>25 mm, CTO, 2-stent bifurcation, calcified or tortuous vessel morphology coronary lesion.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01496651
Study Brief:
Protocol Section:
NCT01496651